Navigation Links
Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
Date:8/20/2007

SAINT LOUIS, Aug. 20 /PRNewswire/ -- The MattsonJack Group, Inc. (MattsonJack), is pleased to announce the promotion of Amit Dhawan M.D., M.B.A., M.P.H. to Medical Director for MattsonJack.

(Photo: http://www.newscom.com/cgi-bin/prnh/20070820/AQM153)

Dr. Dhawan joined MattsonJack in September 2000 as a consultant and Assistant Medical Director after completing his M.D. and M.B.A. from the University of Missouri -- Kansas City. He subsequently earned an M.H.A. from Washington University School of Medicine.

Dr. Robert Ramsey, Vice President and Chief Scientific Officer for MattsonJack stated, "Amit's breadth and depth of clinical knowledge, combined with his commercial insights and the ability to think outside the box have made him one of MattsonJack's most-requested consultants by our clients. He is well-respected for his expertise in clinical medicine, new product analysis, epidemiology, and market trend forecasting, and can help Senior R&D and Commercial Executives make difficult business decisions."

In addition to his accomplishments at MattsonJack, Dr. Dhawan is also very involved in the greater St. Louis community, serving on the board of Cinema St. Louis, serving as the chairperson for the Artsdesire annual gala at the Contemporary Art Museum of St. Louis, and serving on the committee for Connect With, the annual Young Professionals Month organized by Focus St. Louis. For both his professional and civic involvements, Dr. Dhawan earned the recognition of St. Louis Business Journal's 30 Under 30 award. Honorees -- all younger than 30 -- are chosen based on their achievements in career and community.

Executive Vice President Jerry Fields commented, "Dr, Dhawan is a highly regarded individual who brings a unique combination of scientific and commercial perspectives together to help solve client problems. Our clients benefit from his exceptional knowledge and insight.

About The Mattson Jack Group, Inc. (http://www.mattsonjack.com)

Formed in 1986, MattsonJack focuses its client support in three areas of Competency: Business Analytics, Brand Optimization, and Corporate Development services in the pharmaceutical and biotech markets. MattsonJack consultants have expertise in pricing and reimbursement, custom epidemiology, technology assessment, business and strategic plan development, due-diligence and licensing support, market modeling and forecasting, and primary market research. MattsonJack's client list ranges from emerging companies to some of the most recognized pharmaceutical and biotech companies in the world, such as Abbott, Amgen, AstraZeneca, Genentech, GlaxoSmithKline, Johnson & Johnson Companies, Merck, Novartis, Pfizer, Roche, Wyeth and many others.

MattsonJack's knowledgeware and client productivity tools include Epi Database(R) and Forecast Architect(R). Additionally, MattsonJack, as one of the largest global oncology consulting firms supports its client's cancer interests through its MattsonJack DaVinci multi-client offerings including: Cancer!MPact(TM), Oncology Marketing Strategies(TM), Supportive Care Perspectives(TM), Future Focus(TM) Myelodyplastic Syndromes (MDS), and Future Focus(TM) Gastrointestinal Stromal Tumor (GIST).

MattsonJack is part of Kantar Group, the Information and Consultancy division of WPP, an $8+ billion global communications services firm. For more information, contact Geoffrey Arbuckle, Ph.D., Senior Director of Marketing, MattsonJack Public Relations at geoffrey.arbuckle@mattsonjack.com or by phone in the U.S. (+314.529-3034).

About Kantar Group (http://www.kantargroup.com)

Kantar is one of the world's largest research, insight and consultancy networks. It helps clients make better business decisions through a deeper understanding of their markets, their brands and their customers. Part of WPP, Kantar brings together a diverse group of outstanding marketing insight and consulting companies -- each an expert in their field who can work together seamlessly to help clients address business issues in a holistic and strategic way.

Companies include: Added Value Group, IMRB, BMRB, BPRI, Cannondale Associates, Center Partners, Everystone, Focalyst, Fusion 5, Glendinning Management Consultants, Henley Centre HeadlightVision, IMRB, Kantar Operations, KMR Group, Lightspeed Research, Management Ventures, MattsonJack Group, Millward Brown, Research International, RMS and Ziment Group. The group operates in more than 160 offices across 60 markets worldwide.


'/>"/>
SOURCE The Mattson Jack Group, Inc.

Copyright©2007 PR Newswire.

Related biology technology :

1. Hendee promoted to president of MCW Research Foundation; Gutterman steps up
2. Video games promoted as effective health-care training
3. Medical College receives $377K to study brain disease
4. Barriers will not stop convergence of medical technologies
5. Medical College team creates website for tracking flu
6. Biomedical engineering conference invites manufacturers
7. Visions: Wade offers straight talk on e-medical records
8. Merge unveils updated medical imaging software
9. Medical College receives $1.4M cancer grant
10. Medical technology firm lands $100K federal grant
11. Doyle outlines spending for Medical College, UWM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. (API) ... U.S. Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies for ... as hydrophobic nanocellulose compositions. In addition to these patents and U.S. Patent ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... identification of its first three targets, it has identified a fourth in a ... implicated in the development and progression of Alzheimer’s disease (AD). , ...
(Date:5/4/2016)... ... May 04, 2016 , ... Looking for a ... Diego’s premiere hands-on cooking experience. Offering everything from gourmet cooking classes to weekend ... won’t forget. , Guests that visit LaJollaCooks4u share an experience unlike any other. ...
(Date:5/4/2016)... WHIPPANY, N.J. , May 4, 2016 /PRNewswire/ ... evaluating its oncology compound Stivarga ® (regorafenib) ... hepatocellular carcinoma (HCC) has met its primary endpoint ... The study, called RESORCE, evaluated the efficacy and ... disease has progressed after treatment with sorafenib. The ...
Breaking Biology Technology:
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/17/2016)... , March 17, 2016 ABI ... intelligence, forecasts the global biometrics market will reach ... impressive 118% increase from 2015. Consumer electronics, particularly ... embedded fingerprint sensors anticipated to reach two billion ... Dimitrios Pavlakis , Research Analyst at ...
(Date:3/11/2016)... , March 11, 2016 http://www.apimages.com ) ... Cross reference: Picture is available at AP Images ( http://www.apimages.com ) ... DERMALOG will be used to produce the new refugee identity cards. ... biometric innovations, at CeBIT in Hanover next ... from DERMALOG will be used to produce the new refugee identity ...
Breaking Biology News(10 mins):